Comparison of prostate cancer detection rates in patients undergoing MRI/TRUS fusion prostate biopsy with two different software‐based systems

Volume: 82, Issue: 2, Pages: 227 - 234
Published: Nov 3, 2021
Abstract
Background Magnetic resonance imaging (MRI)‐targeted prostate biopsy is a routinely used diagnostic tool for prostate cancer (PCa) detection. However, a clear superiority of the optimal approach for software‐based MRI processing during biopsy procedures is still unanswered. To investigate the impact of robotic approach and software‐based image processing (rigid vs. elastic) during MRI/transrectal ultrasound (TRUS) fusion prostate biopsy (FBx) on...
Paper Details
Title
Comparison of prostate cancer detection rates in patients undergoing MRI/TRUS fusion prostate biopsy with two different software‐based systems
Published Date
Nov 3, 2021
Volume
82
Issue
2
Pages
227 - 234
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.